Insider: ROTHBLATT MARTINE A Chairperson & CEO - UNITED THERAPEUTICS CORP
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 130 | 545,634 | 545,764 |
| Value | $55,538.60 | $233,105,778.84 | $233,161,317.44 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/24/2025 | DDS | 684 | Direct | COM | $435.84 | $298,114.56 | 130 |
| 09/24/2025 | DDS | 3,316 | Direct | COM | $433.77 | $1,438,374.02 | 814 |
| 09/23/2025 | DDS | 2,000 | Direct | COM | $416.51 | $833,020.00 | 2,130 |
| 09/23/2025 | DDS | 2,000 | Direct | COM | $419.79 | $839,572.60 | 130 |
| 09/22/2025 | DDS | 2,000 | Direct | COM | $416.72 | $833,437.60 | 2,130 |
| 09/22/2025 | DDS | 2,000 | Direct | COM | $417.89 | $835,775.00 | 130 |
| 09/19/2025 | DDS | 4,000 | Direct | COM | $411.08 | $1,644,310.00 | 130 |
| 09/18/2025 | DDS | 879 | Direct | COM | $406.04 | $356,905.29 | 130 |
| 09/18/2025 | DDS | 2,000 | Direct | COM | $403.27 | $806,535.00 | 2,130 |
| 09/18/2025 | DDS | 1,121 | Direct | COM | $405.20 | $454,224.83 | 1,009 |
| 09/17/2025 | DDS | 3,135 | Direct | COM | $399.97 | $1,253,906.58 | 995 |
| 09/17/2025 | DDS | 865 | Direct | COM | $400.90 | $346,780.32 | 130 |
| 09/16/2025 | DDS | 1,000 | Direct | COM | $399.28 | $399,281.00 | 3,130 |
| 09/16/2025 | DDS | 3,000 | Direct | COM | $400.59 | $1,201,781.10 | 130 |
| 09/15/2025 | DDS | 1,460 | Direct | COM | $398.19 | $581,355.79 | 130 |
| 09/15/2025 | DDS | 2,540 | Direct | COM | $397.71 | $1,010,179.84 | 1,590 |
| 09/12/2025 | DDS | 1,000 | Direct | COM | $402.21 | $402,210.00 | 3,130 |
| 09/12/2025 | DDS | 2,000 | Direct | COM | $404.89 | $809,780.00 | 130 |
| 09/12/2025 | DDS | 1,000 | Direct | COM | $403.91 | $403,910.00 | 2,130 |
| 09/11/2025 | DDS | 4,000 | Direct | COM | $397.23 | $1,588,904.00 | 130 |
| 09/10/2025 | DDS | 2,000 | Direct | COM | $399.33 | $798,652.80 | 130 |
| 09/10/2025 | DDS | 2,000 | Direct | COM | $398.11 | $796,220.00 | 2,130 |
| 09/09/2025 | DDS | 6,165 | Direct | COM | $398.29 | $2,455,427.03 | 1,965 |
| 09/09/2025 | DDS | 1,835 | Direct | COM | $399.43 | $732,947.26 | 130 |
| 08/26/2024 | DDS | 28 | Direct | COM | $347.27 | $9,723.64 | 371 |
| 1 2 3 4 5 6 7 8 9 10 Next Last You are at page 1 of 130 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research